Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Zhuo XingThe Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-4635-6630
Fuguo WuDepartment of Ophthalmology, Ross Eye Institute, State University of New York at Buffalo, Buffalo, NY 14203, USA.
Eduardo Cortes-GomezDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-0966-6488
Annie PaoThe Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Lingqiu GaoThe Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Avrium DouglasThe Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0009-0005-3203-8112
Yichen LiGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Joseph A SpernyakDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0002-5049-4737
G William WongDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.ORCID 0000-0002-5286-6506
Prashant K SinghDepartment of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Jianmin WangDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0001-7527-0409
Song LiuDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Yasmin ThanavalaDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.ORCID 0000-0003-4802-4952
Ian M MacDonaldDepartment of Ophthalmology, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Xiuqian MuDepartment of Ophthalmology, Ross Eye Institute, State University of New York at Buffalo, Buffalo, NY 14203, USA.ORCID 0000-0002-8003-7529
Y Eugene YuThe Children's Guild Foundation Down Syndrome Research Program, Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Funding
Regulatory mechanisms for retinal ganglion cell genesisR01EY020545 · NEI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Xiuqian Mu · 2011 to 2026
$5.7M
Generation and analysis of new mouse models to determine novel therapeutic targets for Down syndrome-associated cognitive deficitsR01HD109750 · NICHD · ROSWELL PARK CANCER INSTITUTE CORP · PI Eugene Yu · 2022 to 2026
$3.3M
Mentoring For Success: Teaching Faculty Fundamental Skills For Attracting, Admitting and Developing StudentsT32GM144920 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Margarita L Dubocovich · 2022 to 2026
$3.1M
Acquisition of a 7T MR scanner for Translational Imaging Research at Roswell ParkS10OD030397 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI SESHADRI, MUKUND · 2021 to 2021
$2.0M
Regulation of mRNA decay in retinal development and maintenanceR01EY029705 · NEI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MU, XIUQIAN · 2020 to 2023
Choroideremia is a rare X-linked recessive retinal disorder characterized by progressive vision loss caused by retinal degeneration resulting from mutations in the
Indexed as
Adaptor Proteins, Signal TransducingChoroideremiaAnimalsDisease Models, AnimalHumansMaleMiceMice, KnockoutMutationRetinaAdaptor Proteins, Signal Transducingchoroideremiagenetic analysisinflammatory biomarkersinherited retinal degenerationmetabolismmouse mutantsRab escort proteins
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic Analysis of Choroideremia-Related Rab Escort Proteins. · full record | OpenQuestion